A type of radiotherapy that shapes radiation beams to tumors has grabbed headlines today. But more in-depth trials, already underway, are needed to give a clearer picture of the benefit for men.
The Duchess of Gloucester met with researchers and clinical triallists on a royal visit to our Belfast-Manchester Movember Centre of Excellence, where attempts to find new ways to tackle advanced prostate cancer are already showing exciting early results.
Prostate Cancer UK welcomes new data from the STAMPEDE trial that clarifies there is no difference in the benefits offered by both treatments for men newly diagnosed with advanced disease, but now we want the option of earlier abiraterone made available to all men.
Courtney Pine, Gladstone Small and Paul Barber are the latest black celebrities to join our Stronger Knowing More campaign, after our worrying new poll raises fears of a fatal lack of awareness among doctors and patients about black men's higher risk of prostate cancer.
New research shows that taller men have an increased risk of dying from prostate cancer, but how worried should men really be? We take a closer look at the findings...
Researchers at the Institute of Cancer Research have created a powerful new three-in-one blood test, which could help doctors monitor whether a treatment is working and how a man's cancer is responding. We examine the results and find out why it's another step in the creation of targeted treatments for prostate cancer.
Prostate Cancer UK urges people to have vital talks with their relatives and GP about the most common cancer in men, after our new study reveals half of all UK men don't know about their increased risk of the disease if other family members have had it.
BLOG: Our CEO gives her thoughts on what new research could mean for treating prostate cancer and how Prostate Cancer UK is working to make the most of it.
Announced by researchers at a cancer conference in Chicago, the new findings show earlier and combined use of existing treatments can have a significant impact on advanced disease, but questions remain about its suitability for all men.
New research funded by Prostate Cancer UK has discovered a blood test that can predict which men's cancer won't respond to certain hormone therapy, so they can pick the treatment that works for them while saving the NHS potentially huge sums on otherwise wasted drugs.